Hikma Pharmaceutical | HIK - Market Capitalization


Hikma Pharmaceutical reported $3.41B in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Almirall EUR 2.76B 472.53M Dec/2025
argenx SE USD 44.38B 7.45B Mar/2026
AstraZeneca USD 301.25B 13.1B Mar/2026
Bayer EUR 38.69B 2.33B Mar/2026
Genmab DKK 20.48B 1.02B Dec/2025
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Lakefront Biotherapeutics EUR 1.73B 119.93M Mar/2026
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 46.78B 6.52B Mar/2026
Orion EUR 9.83B 890.75M Mar/2026
Recordati EUR 10.26B 104.56M Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.27B 605.48M Mar/2026
UCB EUR 46.41B 13.94B Dec/2025